Anti-Aβ(42)- and anti-Aβ(40)-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model

Accumulation and aggregation of amyloid β peptide 1–42 (Aβ(42)) in the brain has been hypothesized as triggering a pathological cascade that causes Alzheimer disease (AD). To determine whether selective targeting of Aβ(42) versus Aβ(40) or total Aβ is an effective way to prevent or treat AD, we comp...

Full description

Saved in:
Bibliographic Details
Main Authors: Levites, Yona, Das, Pritam, Price, Robert W., Rochette, Marjorie J., Kostura, Lisa A., McGowan, Eileen M., Murphy, Michael P., Golde, Todd E.
Format: Artigo
Language:Inglês
Published: American Society for Clinical Investigation 2006
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1307561/
https://ncbi.nlm.nih.gov/pubmed/16341263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI25410
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items